Abnormal myocardial mechanics in Kawasaki disease: Rapid response to γ- globulin

American Heart Journal

Volumn 139, Issue 2, 2000, Pages 217-223

  Moran, Adrian M ^a   Newburger, Jane W ^a   Sanders, Stephen P ^b   Parness, Ira A ^c   Spevak, Philip J ^d   Burns, Jane C ^e   Colan, Steven D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; IMMUNOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033980737     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90229-1     Document Type: Article

References (35)

1. Kao C, Hsieh K, Wang YL, Chen CW, Liao SQ, Wang SJ, et al. Tc-99m HMPAO WBC imaging to detect carditis and to evaluate the results of high-dose gamma globulin treatment in Kawasaki disease. Clin Nucl Med 1992;17:623-6.
2. Kao C, Hsieh K, Wang Y, Chen CW, Liao SQ, Wang S J, et aL Tc-99m HMPAO labeled WBC scan for the deteclion of myocarditis in different phases of Kawasaki disease. Clin Nucl Med 1992;17:185-90.
3. Matsuura H, Ishikita T, Yammamoto S. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography. Br Heart J 1987;58:385-92.
4. Newburger J, Sanders S, Burns J, Parness I, Beiser A, Colan S. Left ventricular contractility and function in Kawasaki Syndrome. Effect of intravenous gamma-globulin. Circulation 1989;79:1237-46.
5. Marcella J, Ursell P, Goldberger M, Lovejoy W, Fenoglio J, Weiss M. Kawasaki syndrome in an adult: endomyocardial histology and ventriculor function during acute and recovery phases of illness. J Am Coll Cardiol 1983;2:374-8.
6. Kitamura S, Kowashima Y, Kawachi K, Fujino M, Kozuka T. Left ventricular function in patients with coronary arteritis due to acute febrile mucocutaneous lymph node syndrome or related diseases. Am J Cardiol 1977;40:156-64.
7. Anderson T, Meyer R, Kaplan S. Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. Am Heart J 1985;110:107-15.
8. Vogel M, Smallhorn J, Freedom R. Serial analysis of regional left ventricular wall motion by two-dimensional echocardiography in patients with coronary artery enlargement after Kawasaki disease. J Am Coll Cardiol 1992;20:915-9.
9. Kosuda T, Sane K. Assessment of left ventricular function in Kawasaki disease by dipyridamole-loading cineventriculography. Am J Cardiol 1992;70:863-8.
10. Nakana H, Ueda K, Saito A, Nojima K. Left ventricular systolic function in children with coronary arterial lesions following Kawasaki disease. Heart Vessels 1985;1:89-93.
11. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the Fingers and toes in children. Jpn J Allergy 1967; 16:118-22.
12. Kawasaki T, Kosahi F, Okawa S, Shigenatsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MCNS) prevailing in Japan. Pediatrics 1974;54:271-6.
13. Newburger J, Takahashi M, Beiser A, Burns JC, Bastion J, Chung K J, et al. A single intravenous infusion of gamma-globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991 ;324:1664-6.
14. Colan S, Parness I, Spevak P, Sanders S. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992; 19:619-29.
15. Grossman W, Jones D, McLaurin L. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-54.
16. Colan S, Borow K, Neumann A. Left ventricular end-systolic wall stress-velocity of Fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 1984;4:715-24.
17. Research Committee on Kawasaki disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Minister of Health and Welfare; 1984.
18. Yutani C, Go S, Kamiya T, Hirose O, Misawa H, Maeda H, et al. Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med 1981;105:470-3.
19. Yonesaka S, Nakada T, Sunagawa Y, Tomimoto K, Naka S, Takahashi T, et al. Endomyocardial biopsy in children with Kawasaki disease. Acta Pediatrica Japonica 1989;31:706-11.
20. Kao C, Hsieh K, Wang Y, Wang S, Yeh S. The detection of ventricular dysfunction and carditis in children with Kawasaki disease using equilibrium multigated blood pooling ventriculography and 99Tcm-HMPAO-labelled WBC heart scans. Nuc Med Carom 1993;14:539-43.
21. Kao CH, Hsieh KS, Wang YL, Chen CW, Liao SQ, Wang SJ, et al. Comparison of Tc-99m HMPAO labeled white blood cells and 67-Ga citrate scans to detect myocarditis in the acute phase of Kawasaki disease. Nucl Med Comm 1991;12:951-8.
22. Yonesaka S, Tokahashi T, Furukawa H, Matubara T, Tomimoto K, Oura H, et aL Histopathological analysis of myocardial damages following Kawasaki disease with repeated endomyocardial biopsy. Kokyu to Junkun 1992;40:375-81.
23. Yonesaka S, Takahashi T, Matubara T, Nakada T, Furukawo H, Tomimoto K, et al. Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequellae and regional wall motion abnormalities of the left ventricle. Jpn Circ J 1992;56:352-8.
24. Boutin C, Jonas RA, Sanders SP, Wernovsky G, Mane SM, Colan SD. Rapid two-stage arterial switch operation: acquisition of left ventricular mass after pulmonary artery banding in infants with transposition of the great arteries. Circulation 1994;90:1304-9.
25. Barron K. Immune abnormalities in Kawasaki disease: prognostic implications and insight into pathogenesis. Cardiol Young 1991;1:206-11.
26. Leung D, Burns J, Newburger J, Geha R. Reversal of lymphocyte activation in viva in the Kawasaki syndrome by intravenous gamma-globulin. J Clin Invest 1987;79:468-72.
27. Leung D, Caftan R, Kurt-Jones E, Burns J, Newburger J, Pober J. Endothelial cell activation and high interleukin-1 secretion in the palhogenesis of acute Kawasaki disease. Lancet 1989;1:1298-302.
28. Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: a review of risk factors for coronary aneurysms. J Pediatr 1986; 108:388-92.
29. Andersson J, Andersson U. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 1990;71:372-6.
30. Shimozato T, Iwata M, Kawada H, Tamura N. Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3′-5′-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production. Immunology 1991;72:497-501.
31. Amran D, Renz H, Lack G, Bradley K, Gelfand E. Suppression of cytokinedependent human T cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 1994;73:180-6.
32. Lefer A, Rovetto M. Influence of a myocardial depressant factor on physiologic properties of cardiac muscle. Proc Soc Exp Biol 1970;134:269-73.
33. Kelly R, Smith T. Cytokines and cardiac contractile function. Circulation 1997;95:778-81.
34. Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
35. Pagani F, Baker L, Hsi C, Knox M, Fink M, Visner M. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alfa in conscious dogs. J Clin Invest 1992;90:389-98.